Publication trends and hotspots for cervical cancer screening biomarker: a bibliometric analysis
It is a challenge to discover a novel and convenient biomarker to simplify the cervical cancer screening process. Global collaboration and clinical trials in high-incidence countries may contribute to the advancement of biomarker research. HPV testing, p16(ink4a) protein and DNA methylation used to be research hotspots, and they are now applied in clinical practice. Cervico-vaginal microbiota and bioinformatics analysis are the new keywords that have emerged recently.
Authors
- Shuting Zhou
- Min Zhao (ORCID: https://orcid.org/0000-0001-5498-3434)
- Liang‐Ying Liu (ORCID: https://orcid.org/0000-0001-7867-1339)
- Xiangshu Jin (ORCID: https://orcid.org/0000-0002-2568-1135)
- Wen Yang (ORCID: https://orcid.org/0000-0001-5057-8706)
- Yuanguang Meng (ORCID: https://orcid.org/0000-0003-3813-8411)
- Miao Liu (ORCID: https://orcid.org/0000-0003-3042-152X)
- Jia Xu (ORCID: https://orcid.org/0000-0002-8849-2462)
Institutions
- Nankai University (CN)
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1007/s12672-025-02936-y
- Citations
- 2
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 2.71